Immune cells in the myeloma niche
Witryna11 kwi 2024 · Multiple myeloma (MM) is an incurable cancer of the plasma cells. In the last twenty years, treatment strategies have evolved toward targeting MM … Witryna11 sty 2024 · Natural killer (NK) cells represent a subset of CD3- CD7+ CD56+/dim lymphocytes with cytotoxic and suppressor activity against virus-infected cells and …
Immune cells in the myeloma niche
Did you know?
Witryna22 sty 2016 · Multiple myeloma (MM) is a tumor of terminally differentiated B cells that arises in the bone marrow. Immune interactions appear as key determinants of MM … Witryna1 paź 1971 · Immunoglobulins (Ig) on cells of the immune system: The cytotoxicity test, with class-specific and type-specific anti-Ig sera, identifies kappa and micro determinants on mouse lymphocytes. The proportion of kappa(+) cells is characteristic for each source of cells: 30% of bone marrow cells, 40% of c …
WitrynaComplex interactions between tumor plasma cells and the bone marrow (BM) microenvironment contribute to generate an immunosuppressive milieu characterized … WitrynaBone marrow niche in MGUS and SMM. Using single-cell RNA sequencing, our group recently showed that the tumor immune microenvironment can already be altered at …
Witryna10 kwi 2024 · Multiple myeloma is a cancer that affects plasma cells, which develop in the bone marrow and play an important role in the immune system. Bone marrow is … Witryna23 lip 2024 · AML niche shows altered immune cell homing. ... Sanseviero E, Zingoni A, et al. Multiple myeloma impairs bone marrow localization of effector natural killer …
Witryna30 sty 2024 · Lymphoma, a group of widely prevalent hematological malignancies of lymphocyte origin, has become the focus of significant clinical research due to their high propensity for refractory/relapsed (R/R) disease, leading to poor prognostic outcomes. The complex molecular circuitry in lymphomas, especially in the aggressive …
Witryna8 kwi 2024 · Mantle cell lymphoma (MCL), a rare and aggressive B-cell non-Hodgkin lymphoma, mainly develops in the lymph node (LN) and creates a protective and … incongruous activitiesWitryna14 kwi 2024 · Since the dawn of the past century, landmark discoveries in cell-mediated immunity have led to a greater understanding of the innate and adaptive immune systems and revolutionised the treatment of countless diseases, including cancer. Today, precision immuno-oncology (I/O) involves not only targeting immune checkpoints that … incongruous definitionWitrynaEpithelia constitute the outermost barriers of our organisms, protecting us from mechanical, chemical, and biological threats. Specialized immune cells locally coordinate with epithelial cells to optimize epithelial barrier function and tissue surveillance while maintaining physiological exchanges with the environment. … incongruous happeningWitrynaFurthermore, both myeloma cells and myeloid cells residing in the myeloma compartment of the bone marrow niche express uPAR and may contribute to the increased suPAR levels detected in the serum of patients with MM [23,24,25]. uPAR is thought to sustain the homing of malignant plasma cells in the bone marrow along … incongruous as a nounWitryna28 cze 2024 · The role of the main immune components of the myeloma niche along disease evolution and their implication in impairing/improving the response to anti … incongruous noun formWitrynaBackground: Multiple myeloma (MM) cells have an intricate interaction with immune components of the bone marrow (BM) niche that are key for survival and drug … incongruous editingWitryna9 lip 2024 · A growing body of evidence suggests that together with non-hematopoietic stromal cells, BM immune cells with unique functions support the survival of normal … incongruous humor